Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification

被引:50
作者
Foloppe, N [1 ]
Fisher, LM [1 ]
Francis, G [1 ]
Howes, R [1 ]
Kierstan, P [1 ]
Potter, A [1 ]
机构
[1] Vernalis R&D Ltd, Cambridge CB1 6GB, England
关键词
drug design; hydrogen bonds; molecular modelling; molecular recognition; oncology; X-ray crystallography;
D O I
10.1016/j.bmc.2005.10.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of the Chk1 kinase by small molecules binding to its active site is a strategy of great therapeutic interest for oncology. We report how computational modelling predicted the binding mode of ligands of special interest to the Chk1 ATP site, for representatives of an indazole series and debromohymenialdisine. These binding modes were subsequently confirmed by X-ray crystallography. The binding mode of a potent indazole derivative involves non-conventional C-H center dot center dot center dot O and N-H center dot center dot center dot pi-aromatic interactions with the protein. These interactions are formed in a buried pocket at the periphery of the ATP-binding site, the importance of which has previously been overlooked for ligand design against Chk1. It is demonstrated that filling this pocket can confer ligands with dramatically enhanced affinity for Chk1. Structural arguments in conjunction with assay data explain why targeting this pocket is also advantageous for selective binding to Chk1. Structural overlays of known inhibitors complexed with Chk1 show that only the indazole series utilizes the pocket of interest. Therefore, the analysis presented here should prove helpful in guiding future structure-based ligand design efforts against Chk1. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1792 / 1804
页数:13
相关论文
共 86 条
[31]  
Jackson JR, 2000, CANCER RES, V60, P566
[32]   Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells [J].
Jin, P ;
Gu, Y ;
Morgan, DO .
JOURNAL OF CELL BIOLOGY, 1996, 134 (04) :963-970
[33]  
JONES TA, 1993, UPPSALA U UPPSALA SW
[34]  
Kakkar T, 1999, DRUG METAB DISPOS, V27, P756
[35]  
Kakkar T, 2000, J PHARMACOL EXP THER, V293, P861
[36]  
KANIA RS, 2001, Patent No. 0102369
[37]  
Kawabe T, 2004, MOL CANCER THER, V3, P513
[38]   C-H•••O hydrogen bonds in the nuclear receptor RARγ -: a potential tool for drug selectivity [J].
Klaholz, BP ;
Moras, D .
STRUCTURE, 2002, 10 (09) :1197-1204
[39]  
Kohn EA, 2003, CANCER RES, V63, P31
[40]   FREE-ENERGY CALCULATIONS - APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA [J].
KOLLMAN, P .
CHEMICAL REVIEWS, 1993, 93 (07) :2395-2417